Clinipath Malaysia

What Clinipath Malaysia does

Innoquest Pathology Sdn. Bhd., publicly referenced as Clinipath Malaysia, is a Kuala Lumpur-area (Klang-based) clinical pathology laboratory operating in Malaysia since 1994 under the predecessor brand Gribbles Pathology, and rebranded to Innoquest Pathology in May 2022. The company delivers advanced diagnostic testing services — including a comprehensive test menu, on-site screening, phlebotomy, and a courier network for specimen collection — to clinicians, hospitals, medical centres, and their patients across Malaysia. Its core technical platform comprises a single multidisciplinary clinical laboratory with state-of-the-art IT support systems (including an e-Results Portal and a My Specimen patient portal) and operates the only multidisciplinary clinical laboratory in Malaysia holding both College of American Pathology (CAP) and MS ISO 15189 accreditations.

The company generates revenue primarily through professional-service fees on a per-test basis, executed via an enterprise field-sales GTM motion targeting B2B healthcare customers (clinicians, hospitals, medical centres), with a secondary consumer-facing motion serving individual patients. Distribution is direct: courier specimen pickup, on-site screening deployments, and digital result delivery via the e-Results Portal. Marketing relies on social media (Facebook, LinkedIn), CME events, newsletters, and content marketing (Health Matters blog). Supporting the core testing service, the company has built an ancillary ecosystem that includes a lab consumables e-commerce store, continuing medical education programming (Innoquest CME), and patient-facing specimen tracking.

Clinically-led management is positioned as a differentiator: the company states it is the only community-based medical laboratory in Malaysia led and managed by clinicians and seasoned lab operators. The company is privately held (Sdn. Bhd. structure), headquartered in Klang, Malaysia, with 101-250 employees, and has raised at least one disclosed funding round (~$1.79 million from VentureTECH in March 2018). No parent company, subsidiaries, or public-ownership structure is disclosed.

Name

Clinipath Malaysia

Legal name

Innoquest Pathology Sdn. Bhd.

Website

https://clinipath.com.my

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

101–250 employees

Short description

Innoquest Pathology (Clinipath Malaysia) is a Klang-based, clinician-led clinical pathology laboratory serving clinicians, hospitals, and medical centres across Malaysia. It operates the only multidisciplinary lab in the country holding both CAP and MS ISO 15189 accreditations.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB), Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

Keywords

• Clinical pathology services
• Diagnostic laboratory testing
• Specimen collection services
• Medical laboratory testing
• On-site health screening

Headquarters

HQ city

Klang

HQ country

Malaysia

HQ region

Asia

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Pathology Testing Services: Laboratory diagnostic testing services provided to clinicians, hospitals, and medical centres. Services include comprehensive test menu, on-site screening, phlebotomy, and courier services for specimen collection and result delivery.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Multidisciplinary clinical pathology laboratory that delivers advanced diagnostic testing services to clinicians, hospitals, medical centres, and patients in Malaysia. The offering spans a comprehensive test menu, on-site screening and phlebotomy services, courier-based specimen collection, electronic result delivery through the e-Results Portal, and patient-facing specimen tracking via My Specimen. The laboratory is the only multidisciplinary clinical lab in Malaysia holding both College of American Pathology (CAP) and MS ISO 15189 accreditations.

Product overview

Innoquest Pathology is a single unified clinical laboratory service (formerly Gribbles Pathology) offering multidisciplinary diagnostic testing. The core offering includes laboratory tests, on-site screening, phlebotomy services, and courier specimen collection. Supporting services include an e-Results portal for clinicians to access test results, My Specimen portal for patients, a lab consumables store, and Innoquest CME for continuing medical education. The company is the only multidisciplinary clinical laboratory in Malaysia holding both CAP and MS ISO 15189 accreditations.

Differentiator

Problem solved

Functional benefit

Products and services

• Laboratory Tests Comprehensive multidisciplinary clinical pathology test menu covering multiple diagnostic fields, ordered by clinicians, hospitals, and medical centres for the prevention, diagnosis, and treatment of infections, allergies, chronic diseases, cancer, and other medical conditions across all life stages.
• On-Site Screening On-site screening and phlebotomy services brought to clinicians, hospitals, and medical centres, enabling specimen collection at the customer's facility rather than requiring patient travel to a draw centre.
• Courier Services Dedicated courier specimen pickup and logistics service that collects specimens from clinicians, hospitals, and medical centres and transports them to the Innoquest laboratory for processing.
• E-Results Portal Online portal that enables clinicians to access and retrieve electronic test results for their patients, replacing manual result delivery and integrating with the laboratory's diagnostic workflow.
• My Specimen Patient-facing portal that allows individual patients to track the status of their specimens and tests processed by Innoquest Pathology.
• Lab Consumables Store

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Regional players

• Sunway Medical Laboratory: Laboratory services division of Sunway Medical Centre, one of Malaysia's largest private tertiary hospitals. Comparable in serving clinicians and offering outreach testing, though anchored to a single hospital network.
• Subang Jaya Medical Centre Laboratory: Pathology services of Ramsay Sime Darby's flagship SJMC, a leading Malaysian tertiary hospital. Comparable as a hospital-anchored clinical lab serving both internal and external clinicians in the Klang Valley.
• Gleneagles Hospital Kuala Lumpur Laboratory: In-hospital pathology lab of IHH/Gleneagles KL offering diagnostic testing to in-house specialists and external clinicians. Comparable as a private hospital-based lab in the Malaysian market but with narrower external outreach than Innoquest.

Emerging players

• SRL Diagnostics: Asia-Pacific clinical reference lab network with presence across South and Southeast Asia. Comparable to Innoquest as a multi-country reference lab serving hospitals and clinicians with a broad test menu and courier logistics.

Others

• Doctor2U (BookDoc): Malaysian digital health platform offering on-demand home phlebotomy and sample pickup. Comparable to Innoquest's courier and on-site screening services as a digital-enabled specimen collection channel in Malaysia.
• MyHealth360 (IHH Healthcare): IHH Healthcare's patient-facing digital platform combining appointment, telehealth, and lab booking. Comparable to Innoquest's My Specimen and e-Results Portal as a digital patient/clinician touchpoint in the Malaysian diagnostics ecosystem.

Broad incumbents

• Synlab Malaysia: Malaysia subsidiary of Synlab, Europe's largest medical diagnostics chain (formerly Pathology Asia/Gribbles network). Directly comparable as a clinical reference lab, but with global scale and broader test menu reach.
• Quest Diagnostics: One of the world's largest clinical reference laboratories, offering the breadth of esoteric testing and IT connectivity that a top-tier Malaysian lab like Innoquest benchmarks itself against. Relevant as a strategic and operational peer for scale, accreditations, and clinician-portal design.

Direct peers

• KPJ Lablink: Centralized laboratory arm of KPJ Healthcare, Malaysia's largest private hospital group. Operates a multi-site clinical lab network with hospital and external clinician outreach, mirroring Innoquest's reference-lab business model.
• Pantai Premier Pathology: The in-house pathology arm of IHH Healthcare's Pantai hospital network, one of the largest private lab operators in Malaysia. Directly comparable to Innoquest as a multidisciplinary clinical lab serving clinicians and hospitals across the country.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/clinipathmalaysia
• LinkedInlinkedin.com/company/innoquest-diagnostics

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinipath Malaysia